European CHMP Adopts Positive Opinion on Ondexxya™ (andexanet alfa) Portola Pharmaceuticals’ Factor Xa Inhibitor Reversal Agent March 1, 2019 - NASDAQ Companies 0 » View More News for March 01, 2019